Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Abs. Returns |
---|---|---|---|---|
One Week | 2025-06-13 | ₹1,000.00 | ₹979.94 |
-2.01 %
|
Two Week | 2025-06-05 | ₹1,000.00 | ₹993.04 |
-0.70 %
|
One Month | 2025-05-21 | ₹1,000.00 | ₹995.77 |
-0.42 %
|
Three Months | 2025-03-24 | ₹3,000.00 | ₹2,991.11 |
-0.30 %
|
Six Months | 2024-12-23 | ₹6,000.00 | ₹5,976.38 |
-0.39 %
|
One Year | 2024-06-20 | ₹12,000.00 | ₹12,151.31 |
1.26 %
|
Three Year | 2022-06-21 | ₹36,000.00 | ₹49,185.39 |
36.63 %
|
Since Inception | 2021-11-08 | ₹45,000.00 | ₹63,204.56 |
40.45 %
|
Company Name | Sector | Sector Type | Nav(in %) |
---|---|---|---|
Sun Pharmaceutical Industries Limited | Pharmaceuticals & Biotechnology | Equity | 15.18 |
Divi's Laboratories Limited | Pharmaceuticals & Biotechnology | Equity | 9.12 |
Max Healthcare Institute Limited | Healthcare Services | Equity | 5.42 |
Lupin Limited | Pharmaceuticals & Biotechnology | Equity | 5.40 |
Apollo Hospitals Enterprise Limited | Healthcare Services | Equity | 5.19 |
Cohance Lifesciences Limited | Pharmaceuticals & Biotechnology | Equity | 4.84 |
Aurobindo Pharma Limited | Pharmaceuticals & Biotechnology | Equity | 3.93 |
Torrent Pharmaceuticals Limited | Pharmaceuticals & Biotechnology | Equity | 3.91 |
Aster DM Healthcare Limited | Healthcare Services | Equity | 3.15 |
Mankind Pharma Limited | Pharmaceuticals & Biotechnology | Equity | 3.04 |
Alkem Laboratories Limited | Pharmaceuticals & Biotechnology | Equity | 2.87 |
Fortis Healthcare Limited | Healthcare Services | Equity | 2.43 |
Abbott India Limited | Pharmaceuticals & Biotechnology | Equity | 2.33 |
Wockhardt Limited | Pharmaceuticals & Biotechnology | Equity | 2.28 |
Granules India Limited | Pharmaceuticals & Biotechnology | Equity | 2.11 |
Neuland Laboratories Limited | Pharmaceuticals & Biotechnology | Equity | 1.98 |
FDC Limited | Pharmaceuticals & Biotechnology | Equity | 1.55 |
Healthcare Global Enterprises Limited | Healthcare Services | Equity | 1.55 |
Supriya Lifescience Limited | Pharmaceuticals & Biotechnology | Equity | 1.48 |
Sumitomo Chemical India Limited | Fertilizers & Agrochemicals | Equity | 1.43 |
Sagility India Limited | IT - Services | Equity | 1.29 |
Rainbow Childrens Medicare Limited | Healthcare Services | Equity | 1.28 |
JB Chemicals & Pharmaceuticals Limited | Pharmaceuticals & Biotechnology | Equity | 1.23 |
Vijaya Diagnostic Centre Limited | Healthcare Services | Equity | 1.23 |
Shilpa Medicare Limited | Pharmaceuticals & Biotechnology | Equity | 1.22 |
Dr. Reddy's Laboratories Limited | Pharmaceuticals & Biotechnology | Equity | 1.22 |
Gland Pharma Limited | Pharmaceuticals & Biotechnology | Equity | 1.18 |
GlaxoSmithKline Pharmaceuticals Limited | Pharmaceuticals & Biotechnology | Equity | 1.18 |
UPL Limited | Fertilizers & Agrochemicals | Equity | 1.14 |
Onesource Specialty Pharma Limited | Pharmaceuticals & Biotechnology | Equity | 1.09 |
Caplin Point Laboratories Limited | Pharmaceuticals & Biotechnology | Equity | 1.08 |
Linde India Limited | Chemicals & Petrochemicals | Equity | 1.07 |
Orchid Pharma Limited | Pharmaceuticals & Biotechnology | Equity | 1.03 |
Cipla Limited | Pharmaceuticals & Biotechnology | Equity | 1.02 |
Sai Life Sciences Limited | Pharmaceuticals & Biotechnology | Equity | 1.02 |
Strides Pharma Science Limited | Pharmaceuticals & Biotechnology | Equity | 1.01 |
Laurus Labs Limited | Pharmaceuticals & Biotechnology | Equity | 0.97 |
SRF Limited | Chemicals & Petrochemicals | Equity | 0.93 |
TTK Healthcare Limited | Diversified | Equity | 0.32 |
Net Receivables / (Payables) | - | - | 0.30 |
India's "lock-in period" in mutual funds encourages long-term investment, particularly in tax-saving schemes preventing redemption or selling of units.
Lock-in times for various investment types
Residual maturity is the remaining time until a security reaches its maturity date. It is an important factor for investors to consider when evaluating the risk associated with an investment.
There are two different types of residual maturity.
Scheme Name | 1Y Return | 3Y Return | SI Return |
---|---|---|---|
Axis Innovation Fund - Regular Plan - Growth |
9.98%
|
27.76%
|
14.42%
|
Canara Robeco Consumer Trends Fund - Regular Plan - Growth |
9.95%
|
34.58%
|
16.44%
|
NIPPON INDIA QUANT FUND - GROWTH |
9.90%
|
39.46%
|
12.09%
|
NIPPON INDIA QUANT FUND - GROWTH |
9.90%
|
39.46%
|
12.09%
|
BARODA BNP PARIBAS INDIA CONSUMPTION FUND - REGULAR PLAN - GROWTH |
9.90%
|
31.87%
|
18.46%
|
Aditya Birla Sun Life India Reforms Fund - Growth-Regular Plan |
9.88%
|
18.78%
|
8.95%
|
Bajaj Finserv Banking and PSU Fund - Regular Plan - Growth |
9.60%
|
6.82%
|
9.12%
|
LIC MF Banking and PSU Fund - Regular Plan - Growth |
9.52%
|
11.08%
|
7.19%
|
NIPPON INDIA QUANT FUND - INSTITUTIONAL PLAN - GROWTH |
9.51%
|
2.81%
|
3.05%
|
Mirae Asset Banking and PSU Fund - Regular Plan |
9.47%
|
11.15%
|
5.56%
|
Scheme Name | 1Y Return | 3Y Return | SI Return |
---|---|---|---|
ITI Dynamic Bond Fund - Regular Plan - Growth |
9.70%
|
11.07%
|
6.31%
|
ITI Banking and PSU Fund - Regular Plan - Growth |
8.47%
|
10.77%
|
5.88%
|
ITI Small Cap Fund - Regular Plan - Growth |
7.75%
|
47.95%
|
21.26%
|
ITI Conservative Hybrid Fund - Regular Plan - Growth |
7.42%
|
5.34%
|
5.94%
|
ITI Focused Equity Fund - Regular Plan - Growth |
6.98%
|
20.89%
|
21.91%
|
ITI Liquid Fund - Regular Plan - Growth |
6.95%
|
9.96%
|
5.07%
|
ITI Arbitrage Fund - Regular Plan - Growth |
6.95%
|
9.07%
|
4.52%
|
ITI Ultra Short Duration Fund - Regular Plan - Growth |
6.72%
|
9.43%
|
5.22%
|
ITI Overnight Fund - Regular Plan - Growth |
6.20%
|
9.26%
|
4.79%
|
ITI Flexi Cap Fund - Regular Plan - Growth |
6.10%
|
31.36%
|
27.45%
|
Interested in exploring more about JezzMoney Mutual Fund Distributors Software? Submit the form, and we will respond quickly.